<--- Back to Details
First PageDocument Content
Prostate cancer / Lactams / Prostate / Benign prostatic hyperplasia / Cancer / Dutasteride / Prostate-specific antigen / Management of prostate cancer / Medicine / Oncology / Cancer screening
Prostate cancer
Lactams
Prostate
Benign prostatic hyperplasia
Cancer
Dutasteride
Prostate-specific antigen
Management of prostate cancer
Medicine
Oncology
Cancer screening

ODAC 1Dec10 Avodart GSK Slides

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 1,09 MB

Share Document on Facebook

Similar Documents

Uncertainty evaluation of image-based tumour control probability models in radiotherapy of prostate cancer using a visual analytic tool

DocID: 1vnrm - View Document

Abstract # 3991 Novel small molecule inhibitor of p300/CBP down-regulates androgen receptor (AR) and c-Myc for the treatment of prostate cancer and beyond CellCentric

DocID: 1vi4a - View Document

Spring 2014 Issue YES TO LIFE YOUR OPTIONS FOR CANCER Dear Friends and Supporters, In the last Newsletter, we told you about our autumn London Seminar on prostate cancer, the first of our

DocID: 1v4PI - View Document

CANINE BLADDER CANCER by Deborah W. Knapp, DVM, Dipl. ACVIM Cancer of the urinary tract in dogs can affect the kidneys, ureters, urinary bladder, prostate, or urethra (see Figure 1). Within the urinary

DocID: 1uUAX - View Document

Assessment RunERG (Ets-Related Gene) Material The slide to be stained for ERG comprised: 1. Tonsil, 2. Appendix, 3. Prostate with hyperplasia, 4-5. Prostate adenocarcinoma.

DocID: 1uRJi - View Document